Clinical Trial Update: PRX-00023 Therapy in Localization-Related Epilepsy [Phase 2]

View source ↗

Summary

Phase 2 trial update for PRX-00023 in localization-related epilepsy (temporal lobe). Trial status terminated; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial Epilepsy
• Temporal Lobe Epilepsy

Drugs mentioned

• PRX-00023

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Epilepsy, Epilepsy, Temporal Lobe | Phase 2 | Status: TERMINATED | Results posted: 2018-12-07